- CEGConstellation Energy$103BReported
CEGQ2 2026
Constellation Energy
View full reportEPS
Estimated
$2.44
Actual
$1.4241.8%
Revenue
Estimated
$7.6B
Actual
$7.5B1.1%
- KMBKimberly-Clark$33.2BReported
KMBQ2 2026
Kimberly-Clark
View full reportEPS
Estimated
$2.02
Actual
$1.2239.5%
Revenue
Estimated
$4.2B
Actual
$4.2B1.3%
- FERGFerguson$32.8BReported
FERGQ2 2025
Ferguson
View full reportEPS
Estimated
$1.59
Actual
$1.524.5%
Revenue
Estimated
$6.7B
Actual
$6.9B3.3%
- ROIVRoivant Sciences$21.5BReported
ROIVQ1 2027
Roivant Sciences
View full reportEPS
Estimated
-$0.30
Actual
-$0.2614.2%
Revenue
Estimated
$2.3M
Actual
$1.4M38.0%
- AAONAaon$11.7BReported
AAONQ2 2025
Aaon
View full reportEPS
Estimated
$0.31
Actual
$0.1938.7%
Revenue
Estimated
$490.1M
Actual
$311.6M36.4%
- PRAXPraxis$9.8BReported
PRAXQ2 2025
Praxis
View full reportEPS
Estimated
-$3.59
Actual
-$2.8720.1%
Revenue
Estimated
$0.00
Actual
$0.00
- CELHCelsius$8.5BReported
CELHQ2 2025
Celsius
View full reportEPS
Estimated
$0.23
Actual
$0.3343.5%
Revenue
Estimated
$894.3M
Actual
$739.3M17.3%
- IMVTImmunovant$6.9BReported
IMVTQ1 2028
Immunovant
View full reportEPS
Estimated
-$0.60
Actual
-$0.7524.1%
Revenue
Estimated
$0.00
Actual
$0.00
- OSCROscar Health$6.7BReported
OSCRQ2 2025
Oscar Health
View full reportEPS
Estimated
-$0.89
Actual
-$0.890.0%
Revenue
Estimated
$4.8B
Actual
$2.9B40.3%
- KYMRKymera Therapeutics$6.7BReported
KYMRQ2 2025
Kymera Therapeutics
View full reportEPS
Estimated
-$0.78
Actual
-$0.9521.8%
Revenue
Estimated
$29.9M
Actual
$11.5M61.6%
- TDSTDS$4.5BReported
TDSQ2 2025
TDS
View full reportEPS
Estimated
$0.09
Actual
-$0.05157.7%
Revenue
Estimated
$315.8M
Actual
$1.2B275.6%
- ADU.S. Cellular$4.4BReported
ADQ2 2025
U.S. Cellular
View full reportEPS
Estimated
$0.24
Actual
$4.151629.2%
Revenue
Estimated
$52.4M
Actual
$916.0M1646.5%
- USACUSA Compression$4.2BReported
USACQ2 2026
USA Compression
View full reportEPS
Estimated
$0.32
Actual
$0.313.8%
Revenue
Estimated
$332.8M
Actual
$342.1M2.8%
- MNDYMonday.com$4.0BReported
MNDYQ2 2026
Monday.com
View full reportEPS
Estimated
$1.11
Actual
$1.4832.8%
Revenue
Estimated
$355.6M
Actual
$364.6M2.5%
- DASHDoorDash$68.3BReported
DASHQ2 2026
DoorDash
View full reportEPS
Estimated
$0.46
Actual
$0.460.3%
Revenue
Estimated
$4.3B
Actual
$4.5B2.8%
- METMetLife$52.7BReported
METQ2 2026
MetLife
View full reportEPS
Estimated
$2.39
Actual
$1.0954.5%
Revenue
Estimated
$19.8B
Actual
$19.2B3.1%
- XYZBlock Inc.$44.3BReported
XYZQ2 2026
Block Inc.
View full reportEPS
Estimated
$0.87
Actual
$0.1582.7%
Revenue
Estimated
$6.5B
Actual
$6.6B2.1%
- TTWOTake-Two$40.5BReported
TTWOQ1 2027
Take-Two
View full reportEPS
Estimated
$0.33
Actual
-$0.18154.7%
Revenue
Estimated
$1.4B
Actual
$1.5B10.2%
- OKLOOklo$11.8BReported
OKLOQ2 2024
Oklo
View full reportEPS
Estimated
-$0.17
Actual
-$0.2863.8%
Revenue
Estimated
$100.6K
Actual
$1.2M1103.2%
- PINSPinterest$11.6BReported
PINSQ2 2025
Pinterest
View full reportEPS
Estimated
$0.04
Actual
-$0.08300.0%
Revenue
Estimated
$1.1B
Actual
$998.2M13.0%
- CTRECareTrust REIT$9.7BReported
CTREQ2 2025
CareTrust REIT
View full reportEPS
Estimated
$0.42
Actual
$0.3614.3%
Revenue
Estimated
$119.8M
Actual
$112.5M6.1%
- ESEESCO Technologies$7.9BReported
ESEQ3 2025
ESCO Technologies
View full reportEPS
Estimated
$2.10
Actual
$1.0151.8%
Revenue
Estimated
$340.0M
Actual
$296.3M12.8%
- RALRalliant Corp$7.0BReported
RALQ2 2026
Ralliant Corp
View full reportEPS
Estimated
$0.62
Actual
$0.5117.8%
Revenue
Estimated
$550.0M
Actual
$567.8M3.2%
- MACMacerich$6.0BReported
MACQ2 2025
Macerich
View full reportEPS
Estimated
$0.34
Actual
-$0.16147.1%
Revenue
Estimated
$238.5M
Actual
$249.8M4.7%
- HIMSHims & Hers$5.9BReported
HIMSQ2 2025
Hims & Hers
View full reportEPS
Estimated
$0.16
Actual
$0.1918.8%
Revenue
Estimated
$688.6M
Actual
$544.8M20.9%
- PLUGPlug Power$5.7BReported
PLUGQ2 2025
Plug Power
View full reportEPS
Estimated
-$0.15
Actual
-$0.2033.3%
Revenue
Estimated
$168.8M
Actual
$174.0M3.1%
- CRSPCRISPR Therapeutics$5.4BReported
CRSPQ2 2025
CRISPR Therapeutics
View full reportEPS
Estimated
-$1.44
Actual
-$2.4066.7%
Revenue
Estimated
$7.4M
Actual
$892.0K88.0%
- XENEXenon Pharmaceuticals$5.3BReported
XENEQ2 2024
Xenon Pharmaceuticals
View full reportEPS
Estimated
-$1.15
Actual
-$1.113.2%
Revenue
Estimated
$1.4M
Actual
$0.00100.0%
- JBSJbs NV$13.8BReported
JBSQ2 2026
Jbs NV
View full reportEPS
Estimated
$0.37
Actual
$0.2046.5%
Revenue
Estimated
$22.8B
Actual
$23.9B4.6%
- EMBJEmbraer$10.4BReported
EMBJQ2 2026
Embraer
View full reportEPS
Estimated
$0.59
Actual
$1.91225.2%
Revenue
Estimated
$1.9B
Actual
$2.2B15.0%
- CRCLCircle Internet Group Inc$26.9BReported
CRCLQ2 2026
Circle Internet Group Inc
View full reportEPS
Estimated
$0.18
Actual
$0.195.4%
Revenue
Estimated
$731.2M
Actual
$701.3M4.1%
- ARMKAramark$14.0BReported
ARMKQ3 2025
Aramark
View full reportEPS
Estimated
$0.40
Actual
$0.2732.5%
Revenue
Estimated
$4.9B
Actual
$4.6B5.9%
- TMETencent Music$5.4BReported
TMEQ2 2026
Tencent Music
View full reportEPS
Estimated
$0.23
Actual
$1.70638.6%
Revenue
Estimated
$1.3B
Actual
$1.3B1.6%
- ETOReToro Group LTD$3.2BReported
ETORQ2 2026
eToro Group LTD
View full reportEPS
Estimated
$0.60
Actual
$0.6813.1%
Revenue
Estimated
$227.9M
Actual
$229.0M0.5%
- IHSIHS$2.8BReported
IHSQ2 2026
IHS
View full reportEPS
Estimated
$0.15
Actual
-$0.03120.0%
Revenue
Estimated
$437.3M
Actual
$429.0M1.9%
- BLDPBallard Power$1.9BReported
BLDPQ2 2026
Ballard Power
View full reportEPS
Estimated
-$0.05
Actual
-$0.0751.6%
Revenue
Estimated
$27.2M
Actual
$20.6M24.2%
- VIAVia Transportation, Inc$1.2BReported
VIAQ2 2026
Via Transportation, Inc
View full reportEPS
Estimated
-$0.02
Actual
-$0.241163.2%
Revenue
Estimated
$133.4M
Actual
$135.7M1.7%
- ALTAltimmune$597MReported
ALTQ2 2025
Altimmune
View full reportEPS
Estimated
-$0.30
Actual
-$0.2710.0%
Revenue
Estimated
$2.0K
Actual
$5.0K150.0%
- YORWYork Water$483MReported
YORWQ2 2025
York Water
View full reportEPS
Estimated
$0.40
Actual
$0.4922.5%
Revenue
Estimated
$21.3M
Actual
$19.2M9.7%
- EDITEditas$336MReported
EDITQ2 2025
Editas
View full reportEPS
Estimated
-$0.46
Actual
-$0.6337.0%
Revenue
Estimated
$3.0M
Actual
$3.6M19.2%
- FATEFate Therapeutics$307MReported
FATEQ2 2025
Fate Therapeutics
View full reportEPS
Estimated
-$0.35
Actual
-$0.2917.1%
Revenue
Estimated
$1.3M
Actual
$1.9M46.9%
- ALXOALX Oncology$254MReported
ALXOQ2 2024
ALX Oncology
View full reportEPS
Estimated
-$0.14
Actual
-$0.139.0%
Revenue
Estimated
$0.00
Actual
$0.00
- HUYAHUYA$204MReported
HUYAQ2 2026
HUYA
View full reportEPS
Estimated
$0.03
Actual
$0.16464.9%
Revenue
Estimated
$260.2M
Actual
$257.9M0.9%
- KRROKorro Bio$193MReported
KRROQ2 2025
Korro Bio
View full reportEPS
Estimated
-$2.48
Actual
-$2.7410.5%
Revenue
Estimated
$507.4K
Actual
$1.5M187.7%
- LITELumentum$67.0BReported
LITEQ4 2025
Lumentum
View full reportEPS
Estimated
$2.95
Actual
$3.239.5%
Revenue
Estimated
$984.6M
Actual
$1.0B2.2%
- ECGEverus Construction Group Inc$7.7BReported
ECGQ2 2026
Everus Construction Group Inc
View full reportEPS
Estimated
$1.14
Actual
$1.6443.9%
Revenue
Estimated
$1.1B
Actual
$1.2B14.4%
- CNTACentessa$6.2BReported
CNTAQ2 2025
Centessa
View full reportEPS
Estimated
-$0.37
Actual
-$0.382.7%
Revenue
Estimated
$0.00
Actual
$0.00
- GRALGrail Inc$3.2BReported
GRALQ2 2025
Grail Inc
View full reportEPS
Estimated
-$3.13
Actual
-$3.181.6%
Revenue
Estimated
$43.2M
Actual
$35.5M17.6%
- STOKStoke Therapeutics$2.0BReported
STOKQ2 2025
Stoke Therapeutics
View full reportEPS
Estimated
-$0.58
Actual
-$0.9360.3%
Revenue
Estimated
$6.4M
Actual
$13.8M117.0%
- CAPRCapricor$1.7BReported
CAPRQ2 2025
Capricor
View full reportEPS
Estimated
-$0.48
Actual
-$0.5718.7%
Revenue
Estimated
$0.00
Actual
$4.0M
- PGENPrecigen$1.6BReported
PGENQ2 2024
Precigen
View full reportEPS
Estimated
-$0.00
Actual
$0.061900.2%
Revenue
Estimated
$29.5M
Actual
$55.0M86.4%
- HYLNHyliion$1.3BReported
HYLNQ2 2025
Hyliion
View full reportEPS
Estimated
-$0.08
Actual
-$0.080.9%
Revenue
Estimated
$1.6M
Actual
$1.5M2.3%
- ORICORIC Pharmaceuticals$875MReported
ORICQ2 2024
ORIC Pharmaceuticals
View full reportEPS
Estimated
-$0.36
Actual
-$0.386.4%
Revenue
Estimated
$0.00
Actual
$0.00
- SANASana$871MReported
SANAQ2 2024
Sana
View full reportEPS
Estimated
-$0.15
Actual
-$0.2249.8%
Revenue
Estimated
$0.00
Actual
$0.00
- ZVRAZevra$674MReported
ZVRAQ2 2025
Zevra
View full reportEPS
Estimated
-$0.09
Actual
$0.14255.6%
Revenue
Estimated
$34.1M
Actual
$25.9M24.0%
- GAINGladstone Investment$630MReported
GAINQ1 2026
Gladstone Investment
View full reportEPS
Estimated
$0.23
Actual
-$0.30230.4%
Revenue
Estimated
$25.4M
Actual
-$8.5M133.4%
- NPCENeuropace$593MReported
NPCEQ2 2025
Neuropace
View full reportEPS
Estimated
-$0.22
Actual
-$0.2618.2%
Revenue
Estimated
$22.6M
Actual
$23.5M4.3%
- CLLSCellectis SA$263MReported
CLLSQ2 2026
Cellectis SA
View full reportEPS
Estimated
-$0.26
Actual
-$0.1928.0%
Revenue
Estimated
$11.0M
Actual
$5.2M52.3%
- VGVenture Global Inc$31.2BReported
VGQ2 2026
Venture Global Inc
View full reportEPS
Estimated
$0.47
Actual
$0.5415.8%
Revenue
Estimated
$4.6B
Actual
$4.6B0.9%
- LINELineage Inc$10.0BReported
LINEQ2 2026
Lineage Inc
View full reportEPS
Estimated
-$0.20
Actual
-$0.1333.9%
Revenue
Estimated
$1.4B
Actual
$1.4B0.5%
- CAMTCamtek$8.0BReported
CAMTQ2 2026
Camtek
View full reportEPS
Estimated
$0.76
Actual
$0.782.7%
Revenue
Estimated
$130.2M
Actual
$133.2M2.3%
- LQDALiquidia$5.5BReported
LQDAQ2 2025
Liquidia
View full reportEPS
Estimated
-$0.44
Actual
-$0.4911.4%
Revenue
Estimated
$171.0M
Actual
$8.8M94.8%
- MRPMillrose Properties Inc$4.7BReported
MRPQ2 2026
Millrose Properties Inc
View full reportEPS
Estimated
$0.76
Actual
$0.760.4%
Revenue
Estimated
$203.3M
Actual
$196.9M3.2%
- MRXMarex Group plc$3.7BReported
MRXQ2 2026
Marex Group plc
View full reportEPS
Estimated
$1.24
Actual
$1.7238.3%
Revenue
Estimated
$595.9M
Actual
$695.8M16.8%
- NVGSNavigator$1.3BReported
NVGSQ2 2026
Navigator
View full reportEPS
Estimated
$0.51
Actual
$0.8668.5%
Revenue
Estimated
$139.6M
Actual
$167.9M20.3%
- LMRILumexa Imaging Holdings, Inc$740MReported
LMRIQ2 2026
Lumexa Imaging Holdings, Inc
View full reportEPS
Estimated
$0.15
Actual
$0.2037.6%
Revenue
Estimated
$263.1M
Actual
$264.2M0.4%
- OVIDOvid Therapeutics$493MReported
OVIDQ2 2025
Ovid Therapeutics
View full reportEPS
Estimated
-$0.16
Actual
-$0.0662.5%
Revenue
Estimated
$35.0K
Actual
$6.3M17820.0%
- SGMTSagimet Biosciences$449MReported
SGMTQ2 2025
Sagimet Biosciences
View full reportEPS
Estimated
-$0.25
Actual
-$0.263.6%
Revenue
Estimated
$0.00
Actual
$0.00
- ECXECARX$375MReported
ECXQ2 2026
ECARX
View full reportEPS
Estimated
-$0.03
Actual
-$0.030.1%
Revenue
Estimated
$226.7M
Actual
$225.2M0.7%
- VLNValens$369MReported
VLNQ2 2026
Valens
View full reportEPS
Estimated
-$0.04
Actual
-$0.040.0%
Revenue
Estimated
$17.4M
Actual
$18.1M4.1%
- LWAYLifeway Foods$367MReported
LWAYQ2 2025
Lifeway Foods
View full reportEPS
Estimated
$0.26
Actual
$0.287.7%
Revenue
Estimated
$61.4M
Actual
$53.9M12.2%
- PERIPerion$333MReported
PERIQ2 2026
Perion
View full reportEPS
Estimated
$0.08
Actual
$0.0916.1%
Revenue
Estimated
$96.0M
Actual
$98.2M2.3%
- CSCOCisco$468BReported
CSCOQ4 2026
Cisco
View full reportEPS
Estimated
$1.16
Actual
$1.224.9%
Revenue
Estimated
$16.8B
Actual
$17.3B2.6%
- CRWVCoreWeave Inc$58.3BReported
CRWVQ2 2026
CoreWeave Inc
View full reportEPS
Estimated
-$1.05
Actual
-$1.148.4%
Revenue
Estimated
$2.6B
Actual
$2.6B0.3%
- ARXSArxis, Inc$19.2BReported
ARXSQ2 2026
Arxis, Inc
View full reportEPS
Estimated
$0.07
Actual
-$0.01114.8%
Revenue
Estimated
$459.4M
Actual
$500.7M9.0%
- EQXEquinox Gold$9.9BReported
EQXQ2 2026
Equinox Gold
View full reportEPS
Estimated
$0.30
Actual
$0.1646.1%
Revenue
Estimated
$775.8M
Actual
$769.8M0.8%
- SAROStandardAero Inc$9.4BReported
SAROQ2 2026
StandardAero Inc
View full reportEPS
Estimated
$0.33
Actual
$0.309.2%
Revenue
Estimated
$1.6B
Actual
$1.6B0.2%
- RGTIRigetti$9.0BReported
RGTIQ2 2025
Rigetti
View full reportEPS
Estimated
-$0.06
Actual
-$0.16166.7%
Revenue
Estimated
$5.1M
Actual
$1.8M64.9%
- CAICaris Life Sciences Inc$4.7BReported
CAIQ2 2026
Caris Life Sciences Inc
View full reportEPS
Estimated
$0.01
Actual
$0.00100.0%
Revenue
Estimated
$239.9M
Actual
$263.7M9.9%
- INFQChurchill Capital Corp X$3.9BReported
INFQQ2 2026
Churchill Capital Corp X
View full reportEPS
Estimated
—
Actual
-$0.12
Revenue
Estimated
—
Actual
$12.6M
- ERASErasca$3.8BReported
ERASQ2 2025
Erasca
View full reportEPS
Estimated
-$0.14
Actual
-$0.1214.3%
Revenue
Estimated
$0.00
Actual
$715.0K
- MLYSMineralys Therapeutics$2.6BReported
MLYSQ2 2024
Mineralys Therapeutics
View full reportEPS
Estimated
-$0.55
Actual
-$2.85418.2%
Revenue
Estimated
$0.00
Actual
$0.00
- PAGSPagseguro$2.6BReported
PAGSQ2 2026
Pagseguro
View full reportEPS
Estimated
$0.40
Actual
$2.06418.5%
Revenue
Estimated
$992.5M
Actual
$995.1M0.3%
- KODKodiak Sciences$2.3BReported
KODQ2 2024
Kodiak Sciences
View full reportEPS
Estimated
-$0.96
Actual
-$0.8610.3%
Revenue
Estimated
$0.00
Actual
$0.00
- KODKodiak Sciences$2.3BReported
KODQ2 2025
Kodiak Sciences
View full reportEPS
Estimated
-$1.02
Actual
-$1.031.0%
Revenue
Estimated
$0.00
Actual
$1.9M
- PHVSPharvaris$2.1BReported
PHVSQ2 2026
Pharvaris
View full reportEPS
Estimated
-$0.77
Actual
-$0.709.1%
Revenue
Estimated
$0.00
Actual
$0.00
- SUZSuzano SA-ADR$10.2BReported
SUZQ2 2024
Suzano SA-ADR
View full reportEPS
Estimated
$0.23
Actual
-$2.941398.0%
Revenue
Estimated
$2.6B
Actual
$2.0B20.0%
- NYAXNayax Ltd$2.7BReported
NYAXQ2 2026
Nayax Ltd
View full reportEPS
Estimated
$0.13
Actual
$0.148.8%
Revenue
Estimated
$121.5M
Actual
$122.6M0.9%
- AMCRAmcor$18.1BReported
AMCRQ4 2025
Amcor
View full reportEPS
Estimated
$1.19
Actual
$1.233.1%
Revenue
Estimated
$6.1B
Actual
$6.4B5.3%
- SNSharkNinja$16.9BReported
SNQ2 2026
SharkNinja
View full reportEPS
Estimated
$1.09
Actual
$0.9215.4%
Revenue
Estimated
$1.6B
Actual
$1.8B7.2%
- NVMINova$16.1BReported
NVMIQ2 2026
Nova
View full reportEPS
Estimated
$2.41
Actual
$2.514.1%
Revenue
Estimated
$250.3M
Actual
$255.0M1.8%
- AGFirst Majestic$10.2BReported
AGQ2 2026
First Majestic
View full reportEPS
Estimated
$0.18
Actual
$0.2118.5%
Revenue
Estimated
$432.0M
Actual
$415.5M3.8%
- LGNLegence Corp$9.0BReported
LGNQ2 2026
Legence Corp
View full reportEPS
Estimated
$0.38
Actual
-$0.37198.5%
Revenue
Estimated
$1.1B
Actual
$1.3B19.0%
- LOARLoar Holdings Inc$6.1BReported
LOARQ2 2025
Loar Holdings Inc
View full reportEPS
Estimated
$0.15
Actual
$0.1820.0%
Revenue
Estimated
$162.9M
Actual
$123.1M24.4%
- SPHRSphere Entertainment Co$3.3BReported
SPHRQ4 2026
Sphere Entertainment Co
View full reportEPS
Estimated
—
Actual
-$1.07
Revenue
Estimated
—
Actual
$313.6M
- NIQNIQ Global Intelligence plc$2.5BReported
NIQQ2 2026
NIQ Global Intelligence plc
View full reportEPS
Estimated
$0.21
Actual
-$0.10148.5%
Revenue
Estimated
$1.1B
Actual
$1.1B1.7%
- TYRATyra Biosciences$1.9BReported
TYRAQ2 2024
Tyra Biosciences
View full reportEPS
Estimated
-$0.64
Actual
-$0.697.1%
Revenue
Estimated
$0.00
Actual
$0.00
- ATAIAtai$1.6BReported
ATAIQ2 2026
Atai
View full reportEPS
Estimated
-$0.11
Actual
-$0.0916.8%
Revenue
Estimated
$111.1K
Actual
$1.7M1433.6%
- ASSTStrive Inc$1.2BReported
ASSTQ2 2025
Strive Inc
View full reportEPS
Estimated
$0.07
Actual
-$3.865246.7%
Revenue
Estimated
$3.1M
Actual
$173.3K94.3%
- ZURAZura Bio$399MReported
ZURAQ2 2024
Zura Bio
View full reportEPS
Estimated
-$0.18
Actual
-$0.2113.5%
Revenue
Estimated
$0.00
Actual
$0.00
- IVVDInvivyd$333MReported
IVVDQ2 2025
Invivyd
View full reportEPS
Estimated
-$0.02
Actual
-$0.12500.0%
Revenue
Estimated
$14.4M
Actual
$11.8M18.2%
- ABEOAbeona Therapeutics$329MReported
ABEOQ2 2025
Abeona Therapeutics
View full reportEPS
Estimated
-$0.43
Actual
$2.07581.4%
Revenue
Estimated
$12.2M
Actual
$400.0K96.7%
- AMATApplied Materials$357BUpcoming
AMATQ3 2026
Applied Materials
View full reportEPS
Estimated
$3.36
Actual
—
Revenue
Estimated
$8.9B
Actual
—
- QXOQXO$12.8BReported
QXOQ2 2025
QXO
View full reportEPS
Estimated
$0.04
Actual
-$0.15475.0%
Revenue
Estimated
$3.3B
Actual
$1.9B41.7%
- FIGRFigure Technology Solutions Inc$7.7BReported
FIGRQ2 2026
Figure Technology Solutions Inc
View full reportEPS
Estimated
$0.26
Actual
$0.3948.4%
Revenue
Estimated
$201.2M
Actual
$225.6M12.1%
- EXKEndeavour Silver$2.9BReported
EXKQ2 2026
Endeavour Silver
View full reportEPS
Estimated
$0.19
Actual
$0.1522.7%
Revenue
Estimated
$212.4M
Actual
$212.1M0.1%
- AVEXAEVEX Corp$2.4BReported
AVEXQ2 2026
AEVEX Corp
View full reportEPS
Estimated
$0.07
Actual
$0.0186.0%
Revenue
Estimated
$159.8M
Actual
$201.8M26.3%
- HEHawaiian Electric$2.3BReported
HEQ2 2025
Hawaiian Electric
View full reportEPS
Estimated
$0.19
Actual
$0.1522.7%
Revenue
Estimated
$943.4M
Actual
$746.4M20.9%
- NNENano Nuclear Energy Inc$1.5BReported
NNEQ3 2026
Nano Nuclear Energy Inc
View full reportEPS
Estimated
-$0.28
Actual
-$0.1930.9%
Revenue
Estimated
$0.00
Actual
$214.0K
- SBETSharpLink Gaming Inc$1.2BReported
SBETQ2 2026
SharpLink Gaming Inc
View full reportEPS
Estimated
$0.61
Actual
-$1.88408.2%
Revenue
Estimated
$13.7M
Actual
$11.5M16.1%
- EVLVEvolv$1.2BReported
EVLVQ2 2025
Evolv
View full reportEPS
Estimated
-$0.09
Actual
-$0.25177.8%
Revenue
Estimated
$41.8M
Actual
$32.5M22.2%
- SVRASavara$1.0BReported
SVRAQ2 2026
Savara
View full reportEPS
Estimated
-$0.14
Actual
-$0.1610.3%
Revenue
Estimated
$0.00
Actual
$0.00
- JBIOAerovate$1.0BReported
JBIOQ2 2024
Aerovate
View full reportEPS
Estimated
-$0.61
Actual
-$0.7625.1%
Revenue
Estimated
$0.00
Actual
$0.00
- APCARKO Petroleum Corp$910MReported
APCQ2 2026
ARKO Petroleum Corp
View full reportEPS
Estimated
$0.32
Actual
$0.2619.9%
Revenue
Estimated
$1.5B
Actual
$1.8B20.1%
- ANNXAnnexon$880MReported
ANNXQ2 2025
Annexon
View full reportEPS
Estimated
-$0.24
Actual
-$0.3443.9%
Revenue
Estimated
$0.00
Actual
$0.00
- LWLGLightwave Logic$1.8BReported
LWLGQ2 2026
Lightwave Logic
View full reportEPS
Estimated
—
Actual
-$0.04
Revenue
Estimated
—
Actual
$33.0K
- BORRBorr Drilling$1.6BReported
BORRQ2 2026
Borr Drilling
View full reportEPS
Estimated
—
Actual
-$0.79
Revenue
Estimated
—
Actual
$232.3M
- TET1 Energy Inc.$3.0BReported
TEQ2 2024
T1 Energy Inc.
View full reportEPS
Estimated
-$0.08
Actual
-$0.1689.6%
Revenue
Estimated
$203.4M
Actual
$250.1M22.9%
- PLSEPulse Biosciences$1.7BReported
PLSEQ2 2025
Pulse Biosciences
View full reportEPS
Estimated
-$0.26
Actual
-$0.287.7%
Revenue
Estimated
$600.0K
Actual
$0.00100.0%
- WYFIWhiteFiber Inc$1.2BReported
WYFIQ2 2026
WhiteFiber Inc
View full reportEPS
Estimated
-$0.40
Actual
-$0.393.0%
Revenue
Estimated
$20.0M
Actual
$28.8M44.3%
- STTKShattuck Labs$458MReported
STTKQ2 2025
Shattuck Labs
View full reportEPS
Estimated
-$0.13
Actual
-$0.129.9%
Revenue
Estimated
$0.00
Actual
$0.00
- CMPXCompass$434MReported
CMPXQ2 2025
Compass
View full reportEPS
Estimated
-$0.13
Actual
-$0.147.7%
Revenue
Estimated
-$654.5K
Actual
$0.00100.0%
- AUTLAutolus$415MReported
AUTLQ2 2026
Autolus
View full reportEPS
Estimated
-$0.23
Actual
-$0.1533.4%
Revenue
Estimated
$30.1M
Actual
$45.7M51.9%
- XXII22nd Century Group$2.5MReported
XXIIQ2 2025
22nd Century Group
View full reportEPS
Estimated
-$2.10
Actual
-$13.61548.1%
Revenue
Estimated
$4.0M
Actual
$4.1M0.8%
- FIGFigma Inc$12.4BReported
FIGQ2 2026
Figma Inc
View full reportEPS
Estimated
$0.04
Actual
-$0.21614.4%
Revenue
Estimated
$349.3M
Actual
$370.1M5.9%
- STNStantec Inc$8.6BReported
STNQ2 2026
Stantec Inc
View full reportEPS
Estimated
$1.16
Actual
$1.6138.7%
Revenue
Estimated
$1.3B
Actual
$1.3B2.4%
- RUMRumble$3.2BReported
RUMQ2 2026
Rumble
View full reportEPS
Estimated
-$0.09
Actual
-$0.28211.1%
Revenue
Estimated
$31.2M
Actual
$40.4M29.3%
- WBTNWEBTOON Entertainment Inc$1.6BReported
WBTNQ2 2025
WEBTOON Entertainment Inc
View full reportEPS
Estimated
-$0.07
Actual
-$0.0358.4%
Revenue
Estimated
$339.4M
Actual
$348.3M2.6%
- UAMYUnited States Antimony Corporation$1.3BReported
UAMYQ2 2026
United States Antimony Corporation
View full reportEPS
Estimated
$0.01
Actual
$0.00100.0%
Revenue
Estimated
$25.0M
Actual
$7.9M68.3%
- NMAXNewsmax Inc$1.1BReported
NMAXQ2 2026
Newsmax Inc
View full reportEPS
Estimated
-$0.04
Actual
$0.02150.0%
Revenue
Estimated
$48.4M
Actual
$54.1M11.8%
- LYELLyell Immunopharma$393MReported
LYELQ2 2025
Lyell Immunopharma
View full reportEPS
Estimated
-$3.99
Actual
-$2.8927.6%
Revenue
Estimated
$5.5K
Actual
$8.0K45.5%
- RDNWRumbleON$313MReported
RDNWQ2 2026
RumbleON
View full reportEPS
Estimated
$0.12
Actual
$0.1741.7%
Revenue
Estimated
$319.7M
Actual
$296.8M7.2%
- GRWGGrowGeneration$107MReported
GRWGQ2 2025
GrowGeneration
View full reportEPS
Estimated
-$0.04
Actual
-$0.08102.2%
Revenue
Estimated
$42.4M
Actual
$41.0M3.4%
- FFAIFaraday Future Intelligent Electric Inc$95.6MReported
FFAIQ2 2026
Faraday Future Intelligent Electric Inc
View full reportEPS
Estimated
-$0.41
Actual
-$17.384139.0%
Revenue
Estimated
$413.0K
Actual
$836.0K102.4%
- CODXCo-Diagnostics$40.3MReported
CODXQ2 2026
Co-Diagnostics
View full reportEPS
Estimated
-$3.60
Actual
-$1.4659.4%
Revenue
Estimated
$127.1K
Actual
$166.1K30.8%
- TELATELA Bio$40.3MReported
TELAQ2 2025
TELA Bio
View full reportEPS
Estimated
-$0.17
Actual
-$0.2226.7%
Revenue
Estimated
$20.0M
Actual
$20.2M0.9%